• Neomycin Sulfate as a Mechanistic Assay Probe

  2026-09-18

  Neomycin sulfate is an aminoglycoside antibiotic with unusually broad value as a probe of RNA, DNA, and ion-channel behavior. This article presents an assay-design framework that connects its molecular mechanisms with microbiome–immune research while clearly separating established evidence from practical recommendations.

• α-Amanitin: RNA Polymerase II Inhibition

  2026-09-18

  α-Amanitin is a cyclic peptide toxin and selective RNA polymerase II inhibitor that blocks transcriptional elongation. Its defined mechanism, product specifications, and reported embryo-activity benchmark support transcriptional regulation research and preimplantation embryo development study design.

• ARID1A-Dependent Resistance in Melanoma Multi-Omics

  2026-09-17

  The reference study integrates early signaling, molecular abundance, and network-level analyses to explain how ARID1A loss reshapes response to BRAF/MAPK inhibition in melanoma. Its identification of PRKD1, JUN, and NCK1 as resistance-associated nodes provides a focused framework for validating adaptive signaling and immune-related changes in cancer biology workflows.

• β-Amanitin Workflows for RNA Polymerase II Studies

  2026-09-17

  β-Amanitin enables mechanism-focused experiments that connect RNA polymerase II inhibition with transcriptional regulation, mRNA synthesis, and protein-expression phenotypes. This guide also shows how beta-amanitin can support toxin-reference and biosensing workflows while separating cell-based interpretation from analytical detection.

• Reading Matrix Biology: Alcian Blue at pH 2.5

  2026-09-16

  A translational framework for using Alcian Blue and Nuclear Fast Red dual staining to connect extracellular-matrix biology, chondrogenic differentiation, and small-tissue workflow design. The article explains the chemistry, evidence boundaries, assay strategy, and practical value of the Alcian Blue & Nuclear Fast Red Staining Kit, pH2.5.

• Light-Controlled RNA Release for Gene Therapy

  2026-09-16

  The reference study introduces a rationally designed light-inducible RNA-releasing protein (LIRP) that regulates therapeutic protein production at the translation stage. By combining LIRP with AAV-based delivery, the authors demonstrate light-dependent control of obesity-related and retinal gene therapies in mice, highlighting a potential safety and dosing advantage over constitutive expression.

• DdmDE Plasmid Defense and Bidirectional DNA Extrusion

  2026-09-15

  Yang et al. define a dynamic plasmid-clearance mechanism in which DNA-guided Argonaute DdmE recognizes transiently destabilized DNA and recruits DdmD to unwind both directions from the target. The study shows that weak, spatially separated nuclease activity becomes effective when free DdmD coats the extruded single-stranded DNA, offering a mechanistic framework for accessory-factor-dependent bacterial defense.

• CDK9 inhibitor (A3294): Protocol and QC Guide

  2026-09-15

  CDK9 inhibitor (A3294) is a selective serine/threonine kinase inhibitor for controlled studies of transcription elongation, P-TEFb function, and HIV-1 propagation. It is appropriate for defined biochemical and cellular assays, but not for broad CDK inhibition, generalized antiviral claims, or long-term storage of working solutions.

• Dabigatran for Reliable Thrombin-Linked Cell Assays

  2026-09-14

  This scenario-driven guide explains how Dabigatran SKU A4077 can help researchers separate thrombin-dependent biology from nonspecific effects in coagulation, vascular-cell, and viability workflows. It covers assay compatibility, concentration design, metabolite-aware interpretation, and practical vendor selection using data-backed product specifications.

• PKM2 Inhibitor (Compound 3k): Metabolism to Immunity

  2026-09-14

  PKM2 inhibitor (compound 3k) connects tumor glycolysis, selective antiproliferative activity, and macrophage immunometabolism. This article interprets the compound through a cross-domain framework that distinguishes biochemical inhibition, cell-specific responses, and pathway-level evidence.

• Naloxone Hydrochloride in Opioid Research

  2026-09-13

  Naloxone hydrochloride is a reversible opioid receptor antagonist for dissecting receptor signaling, withdrawal-associated behavior, and pharmacological rescue paradigms. This guide translates its receptor-blocking activity into practical cell, behavioral, neural stem cell, and immune research workflows with formulation and troubleshooting guidance.

• Sumatriptan’s Anti-Inflammatory Evidence Review

  2026-09-12

  This systematic review reframes sumatriptan as a potential anti-inflammatory agent by connecting 5-HT1B/1D receptor pharmacology with cytokine, nitric oxide, CGRP, and cell-survival pathways. Its main practical value is hypothesis generation: the evidence supports further mechanistic and translational studies, but heterogeneous preclinical models do not yet establish a broad clinical anti-inflammatory indication.

• Caffeic Acid Phenethyl Ester (CAPE) Assays

  2026-09-11

  A scenario-based guide to using Caffeic Acid Phenethyl Ester (CAPE), SKU B1644, in NF-κB, viability, inflammation, angiogenesis, and neurodegeneration workflows. It addresses vehicle controls, dose selection, pathway interpretation, protocol parameters, and practical supplier evaluation.

• Sumatriptan Succinate: A Translational Research Lens

  2026-09-11

  Sumatriptan Succinate is more than a migraine intervention: it is a route-aware 5-HT1 receptor agonist for studying neurovascular signaling, CGRP biology, inflammation, and metabolism. This thought-leadership article connects mechanism, assay design, pediatric emergency evidence, and strategic workflow decisions for translational researchers.

• RNA Clean and Concentrator Kit for IVT mRNA

  2026-09-10

  The RNA Clean and Concentrator Kit streamlines RNA purification from enzymatic reactions, including in vitro transcription workflows that generate mRNA for lipid nanoparticle studies. Its membrane-based format supports fragment-selective cleanup, high-throughput processing, and practical recovery planning from nanogram to microgram-scale inputs.

595 records 7/40 page Previous Next First page 上5页 678910 下5页 Last page